Entrada Therapeutics
TRDA
#6187
Rank
ยฃ0.53 B
Marketcap
ยฃ14.34
Share price
0.67%
Change (1 day)
7.88%
Change (1 year)

Entrada Therapeutics (TRDA) - Cash on Hand

Cash on Hand as of September 2024 : ยฃ0.35 Billion

According to Entrada Therapeutics's latest financial reports the company has ยฃ0.35 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Entrada Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ0.27 B77.11%
2022-12-31ยฃ0.15 B-27.66%
2021-12-31ยฃ0.21 B652.76%
2020-12-31ยฃ28.64 M123%
2019-12-31ยฃ12.84 M